Taiwan FDA registration a28dc25452477a1257a6f2e5eeef1670
“Seawon” Claudicare Percutaneous Endoscopic Neurolysis and Foraminoplasty System
TW: “希旺”克勞蒂椎間孔成形術器具組
Taiwan·Risk Class 2·MD·Seawon Meditech Co., Ltd.·Registered Jul 17, 2018 – Jul 17, 2028ActiveRegistration details
- Analysis ID
- a28dc25452477a1257a6f2e5eeef1670
- License Form
- Ministry of Health Medical Device Import No. 031300
- Customs Code
- DHA05603130001
Company information
- Manufacturer
- Seawon Meditech Co., Ltd.
- Manufacturer Country
- Korea, Republic of
- Authorized Representative
- BUTICON INTERNATIONAL CORPORATION
Product details
- Intended Use
- For details, it is Chinese approved copy of the imitation order
- Product Type (Level 1)
- N Orthopedic devices
- Product Type (Level 2)
- N1100 Arthroscopy
- Import Information
- Imported from abroad
Dates and status
- Registration Date
- Jul 17, 2018
- Expiry Date
- Jul 17, 2028
About this record
Access comprehensive regulatory information for “Seawon” Claudicare Percutaneous Endoscopic Neurolysis and Foraminoplasty System in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number a28dc25452477a1257a6f2e5eeef1670 and manufactured by Seawon Meditech Co., Ltd.. The authorized representative in Taiwan is BUTICON INTERNATIONAL CORPORATION.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices